Question · asked by 1 review
Beta‐blockers vs placebo: Total cardiovascular disease
- Population
- Not specified
- Intervention
- Beta‐blockers
- Comparison
- placebo
- Outcome
- Total cardiovascular disease
Beta‐blockers may leads to lower total cardiovascular disease compared with placebo (low certainty).
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Beta‐blockers vs placebo Total cardiovascular disease Beta‐blockers may leads to lower total cardiovascular disease compared with placebo (low certainty). Beta‐blockers for hypertension (2017) · Cochrane Headline outcomes only | RR 0.88 [0.79, 0.97] | 4 studies · 23613 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Beta‐blockers for hypertension 2017 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Beta‐blockers vs diuretics · 1 review
- Beta‐blockers vs calcium channel blockers · 1 review
- Beta‐blockers vs renin‐angiotensin system inhibitors · 1 review
- Beta‐blockers vs renin‐angiotensin system inhibitors · patients with hypertension · 0 reviews
- Beta‐blockers vs placebo · patients with hypertension · 0 reviews
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.